• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体-1调节巨噬细胞介导的细胞衰老:特发性肺纤维化的一个风险因素。

Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.

作者信息

Lin Cong, Rezaee Farhad, Waasdorp Maaike, Shi Kun, van der Poll Tom, Borensztajn Keren, Spek C Arnold

机构信息

Center for Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen,The Netherlands.

出版信息

Oncotarget. 2015 Nov 3;6(34):35304-14. doi: 10.18632/oncotarget.6095.

DOI:10.18632/oncotarget.6095
PMID:26474459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4742106/
Abstract

Idiopathic pulmonary fibrosis (IPF) is a destructive disease in part resulting from premature or mature cellular aging. Protease-activated receptor-1 (PAR-1) recently emerged as a critical component in the context of fibrotic lung diseases. Therefore, we aimed to study the role of macrophages in PAR-1-mediated idiopathic pulmonary fibrosis. The number of macrophages were significantly reduced in lungs of PAR-1 antagonist (P1pal-12) treated animals upon bleomycin instillation. In line with these data, PAR-1 stimulation increased monocyte / macrophage recruitment in response to epithelium injury in in vitro trans-well assays. Moreover, macrophages induced fibroblasts migration, differentiation and secretion of collagen, which were inhibited in the presence of TGF-β receptor inhibitors. Interestingly, these profibrotic effects were partially inhibited by treatment with the PAR-1 inhibitor P1pal-12. Using shRNA mediated PAR-1 knock down in fibroblasts, we demonstrate that fibroblast PAR-1 contributes to TGF-β activation and production. Finally, we show that the macrophage-dependent induction of PAR-1 driven TGF-β activation was mediated by FXa. Our data identify novel mechanisms by which PAR-1 stimulation on different cell types can contribute to IPF and identify macrophages as key players in PAR-1 dependent development of this devastating disease. IPF may result from cellular senescence mediated by macrophages in the lung.

摘要

特发性肺纤维化(IPF)是一种具有破坏性的疾病,部分原因是细胞过早或成熟衰老。蛋白酶激活受体-1(PAR-1)最近成为纤维化肺病中的关键成分。因此,我们旨在研究巨噬细胞在PAR-1介导的特发性肺纤维化中的作用。在博来霉素滴注后,用PAR-1拮抗剂(P1pal-12)处理的动物肺中巨噬细胞数量显著减少。与这些数据一致,在体外Transwell实验中,PAR-1刺激增加了对上皮损伤的单核细胞/巨噬细胞募集。此外,巨噬细胞诱导成纤维细胞迁移、分化和分泌胶原蛋白,而在存在转化生长因子-β(TGF-β)受体抑制剂的情况下这些作用受到抑制。有趣的是,用PAR-1抑制剂P1pal-12处理可部分抑制这些促纤维化作用。通过在成纤维细胞中使用短发夹RNA(shRNA)介导的PAR-1敲低,我们证明成纤维细胞PAR-1有助于TGF-β的激活和产生。最后,我们表明巨噬细胞依赖性诱导的PAR-1驱动的TGF-β激活是由凝血因子Xa(FXa)介导的。我们的数据确定了PAR-1刺激不同细胞类型可导致IPF的新机制,并确定巨噬细胞是这种毁灭性疾病PAR-1依赖性发展中的关键因素。IPF可能由肺中巨噬细胞介导的细胞衰老引起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/9ad905886844/oncotarget-06-35304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/5286a4c6dbba/oncotarget-06-35304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/45c699750a85/oncotarget-06-35304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/aeacf7dacc6a/oncotarget-06-35304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/f511aa7c70a0/oncotarget-06-35304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/9ad905886844/oncotarget-06-35304-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/5286a4c6dbba/oncotarget-06-35304-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/45c699750a85/oncotarget-06-35304-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/aeacf7dacc6a/oncotarget-06-35304-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/f511aa7c70a0/oncotarget-06-35304-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a4a/4742106/9ad905886844/oncotarget-06-35304-g005.jpg

相似文献

1
Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.蛋白酶激活受体-1调节巨噬细胞介导的细胞衰老:特发性肺纤维化的一个风险因素。
Oncotarget. 2015 Nov 3;6(34):35304-14. doi: 10.18632/oncotarget.6095.
2
Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.蛋白酶激活受体(PAR)-2是肺纤维化中PAR-1信号传导所必需的。
J Cell Mol Med. 2015 Jun;19(6):1346-56. doi: 10.1111/jcmm.12520. Epub 2015 Feb 16.
3
Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.靶向蛋白酶激活受体-1 用 P1pal-12 限制博来霉素诱导的肺纤维化。
Thorax. 2014 Feb;69(2):152-60. doi: 10.1136/thoraxjnl-2013-203877. Epub 2013 Sep 12.
4
Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.蛋白酶激活受体(PAR)-1 和 -3 驱动肺泡上皮细胞的上皮-间充质转化 - 在肺纤维化中的潜在作用。
Thromb Haemost. 2013 Aug;110(2):295-307. doi: 10.1160/TH12-11-0854. Epub 2013 Jun 6.
5
Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.蛋白酶激活受体-2 在特发性肺纤维化中的作用。
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1703-14. doi: 10.1164/rccm.201009-1479OC. Epub 2011 Mar 11.
6
Iron-laden macrophage-mediated paracrine profibrotic signaling induces lung fibroblast activation.铁负荷巨噬细胞介导的旁分泌促纤维化信号诱导肺成纤维细胞激活。
Am J Physiol Cell Physiol. 2024 Oct 1;327(4):C979-C993. doi: 10.1152/ajpcell.00675.2023. Epub 2024 Aug 26.
7
M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.M2巨噬细胞通过TGF-β/Smad2信号通路诱导上皮-间质转化。
Cell Biol Int. 2017 Sep;41(9):960-968. doi: 10.1002/cbin.10788. Epub 2017 Jul 9.
8
Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.特发性肺纤维化中过氧化物酶体受损,这是一个通过转化生长因子-β信号传导诱导更高纤维化反应的恶性循环。
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):E2048-57. doi: 10.1073/pnas.1415111112. Epub 2015 Apr 6.
9
Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.TIM-3 在巨噬细胞中的过表达加剧了小鼠肺纤维化的发病机制。
Am J Respir Cell Mol Biol. 2019 Dec;61(6):727-736. doi: 10.1165/rcmb.2019-0070OC.
10
Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.膜锚定丝氨酸蛋白酶胃蛋白酶原激活因子是肺纤维化形成的触发因素。
Am J Respir Crit Care Med. 2016 Apr 15;193(8):847-60. doi: 10.1164/rccm.201502-0299OC.

引用本文的文献

1
Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.Smad转录因子作为7次跨膜G蛋白偶联受体信号传导的介质。
Acta Pharmacol Sin. 2025 Apr;46(4):795-804. doi: 10.1038/s41401-024-01413-6. Epub 2024 Nov 6.
2
Cell sheet produced from periodontal ligament stem cells activated by PAR1 improves osteogenic differentiation.由 PAR1 激活的牙周韧带干细胞产生的细胞片层可促进成骨分化。
Braz Oral Res. 2024 Sep 2;38:e079. doi: 10.1590/1807-3107bor-2024.vol38.0079. eCollection 2024.
3
Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.

本文引用的文献

1
Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.尼达尼布和吡非尼酮。用于特发性肺纤维化的新型抗纤维化治疗带来了希望,也引发了一些问题。
Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED.
2
Combination therapy: the future of management for idiopathic pulmonary fibrosis?联合治疗:特发性肺纤维化治疗的未来?
Lancet Respir Med. 2014 Nov;2(11):933-942. doi: 10.1016/S2213-2600(14)70232-2. Epub 2014 Nov 3.
3
Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.
凝血因子Xa对PAR1、PAR2和PAR4的表达无影响,对HL-1细胞无促炎作用。
Cells. 2023 Dec 15;12(24):2849. doi: 10.3390/cells12242849.
4
Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.活化的凝血因子X(FXa)通过促进视网膜色素上皮(RPE)上皮-间质转化,促进外伤性增殖性玻璃体视网膜病变(PVR)的发展。
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):29. doi: 10.1167/iovs.62.9.29.
5
Thrombin generation and activity in multiple sclerosis.多发性硬化症中的凝血酶生成和活性。
Metab Brain Dis. 2021 Mar;36(3):407-420. doi: 10.1007/s11011-020-00652-w. Epub 2021 Jan 7.
6
CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis.CCAAT/增强子结合蛋白δ(C/EBPδ)缺乏不影响博来霉素诱导的肺纤维化。
J Clin Transl Res. 2018 Feb 21;3(Suppl 2):358-365. eCollection 2018 Jul 30.
7
Protease-activated receptor-1 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy.蛋白酶激活受体-1 在慢性阻塞性肾病期间导致肾损伤和间质纤维化。
J Cell Mol Med. 2019 Feb;23(2):1268-1279. doi: 10.1111/jcmm.14028. Epub 2018 Nov 28.
8
PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer.肿瘤细胞上的PAR1信号通过维持胰腺癌的间充质表型来限制肿瘤生长。
Oncotarget. 2018 Aug 10;9(62):32010-32023. doi: 10.18632/oncotarget.25880.
9
Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.TGF-β/ALK5 和 PAR2/PAR1 的信号串扰:控制纤维化和癌症的复杂调控网络。
Int J Mol Sci. 2018 May 24;19(6):1568. doi: 10.3390/ijms19061568.
10
Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner.纤溶酶以一种不依赖蛋白酶激活受体-1的方式减少系膜细胞中纤连蛋白的沉积。
Biochem Biophys Rep. 2017 Mar 29;10:152-156. doi: 10.1016/j.bbrep.2017.03.009. eCollection 2017 Jul.
蛋白酶激活受体-1缺乏可减轻博来霉素诱导的皮肤纤维化。
Mol Med. 2014 Sep 18;20(1):410-6. doi: 10.2119/molmed.2014.00027.
4
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化患者的 3 期临床试验。
N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18.
5
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.尼达尼布治疗特发性肺纤维化的疗效和安全性。
N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18.
6
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance.蛋白酶激活受体-1驱动胰腺癌进展和化疗耐药。
Int J Cancer. 2014 Nov 15;135(10):2294-304. doi: 10.1002/ijc.28726. Epub 2014 Jun 19.
7
Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.靶向蛋白酶激活受体-1 用 P1pal-12 限制博来霉素诱导的肺纤维化。
Thorax. 2014 Feb;69(2):152-60. doi: 10.1136/thoraxjnl-2013-203877. Epub 2013 Sep 12.
8
Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.p21 激活激酶 2 在凝血酶诱导的单核细胞迁移中的新作用。
J Biol Chem. 2013 Oct 25;288(43):30815-31. doi: 10.1074/jbc.M113.463414. Epub 2013 Sep 11.
9
Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.蛋白酶激活受体(PAR)-1 和 -3 驱动肺泡上皮细胞的上皮-间充质转化 - 在肺纤维化中的潜在作用。
Thromb Haemost. 2013 Aug;110(2):295-307. doi: 10.1160/TH12-11-0854. Epub 2013 Jun 6.
10
Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.蛋白酶激活受体 1 抑制剂 SCH79797 可减轻左心室重构和心脏成纤维细胞的促纤维化活性。
J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):460-75. doi: 10.1177/1074248413485434. Epub 2013 Apr 17.